Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tegafur
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 30 for your search:
Start Over
Phase II-III Chemotherapy with Ftorafur vs 5-FU/MeCCNU/TZT vs 5-FU/MeCCNU/ICRF-159 vs 5-FU/MeCCNU/VCR for Advanced Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-764802
Combination Chemotherapy in Treating Patients With Resected Colon Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: NSABP C-06, U10CA012027, NCT00378716
Phase III Oral Tegafur vs Intravenous 5-Fluorouracil for Advanced Carcinoma of the Colon and Rectum
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCCRC-2993, NCI-V83-0142
Phase I/II Study of Oral UFT (Uracil/Tegafur) with CF for Advanced Solid Tumors (Summary Last Modified 07/95)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-92037A1, NCI-V92-0097
Phase II Study of Oral Uracil and Tegafur Plus Leucovorin Calcium in Advanced Local-Regional or Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 03/2000)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DFCI-96082, BMS-CA146-020, MGH-M6-37, NCI-G98-1384
Phase II Chemotherapy with Ftorafur for Metastatic Adenocarcinoma of the Colon and Rectum
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7619
Phase II Chemotherapy with MeCCNU/TGDR vs MITO/TGDR vs MITO/5-FU for Refractory Disseminated Colorectal Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7634
Phase II Comparison of Ftorafur/MITO-C vs Ftorafur/MeCCNU for Adenocarcinoma of the Colon and Rectum
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-19676
Phase II Chemotherapy with Ftorafur for Adenocarcinoma of the Colon and Rectum After Prior Treatment with 5-FU or FUDR
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-20276
Phase II Evaluation of Ftorafur for Advanced Squamous Cell and Adenocarcinomas of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-22077
Phase II Chemotherapy with Ftorafur for Untreated Adenocarcinoma of the Colon
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: WSU-C-24577
Phase II Trials of 13 Additional Chemotherapeutic Agents, Alone or Combined for non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2575-II
Phase II Chemotherapy with ADR/BCNU/Ftorafur for Advanced Gastric, Pancreatic and Other Upper GI Carcinomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7552
Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07_DOG03_133, NCT01225744
A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TPU-S1108, NCT00400023
Radiotherapy plus Chemotherapy with Dibromodulcitol/Ftorafur/ADR for Breast Carcinoma Metastatic to Brain
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7736
Chemotherapy with FACP (Ftorafur/ADR/CTX/CACP) with or without Immunotherapy with Thymosin for non-Oat Cell Carcinoma of the Lung
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7653A
Chemotherapy with FACP (Ftorafur/ADR/CTX/CACP) with or without Thymosin or Intravenous Hyperalimentation for Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7751
Chemotherapy with FACP (FT/ADR/CTX/CACP) with and without Thymosin Immunotherapy for Metastatic Squamous Cell Lung Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7752
Chemotherapy with Oral Ftorafur vs Intravenous 5-Fluorouracil for Advanced Colon and Rectal Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7920
Chemotherapy with Ftorafur with and without CAP (ADR/CTX/CACP) for Metastatic Adenocarcinoma of Unknown Primary Origin
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7917
Chemotherapy with ADR/CTX/Ftorafur and Immunotherapy with BCG for Stage IV Breast Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7515
Chemotherapy with Ftorafur and Baker's Antifol plus C. Parvum Adjuvant Immunotherapy for Metastatic Adenocarcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7513
Phase III Chemotherapy with ADR/5-FU vs BCNU/ADR/FT for Disseminated Pancreatic Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: NCOG-3P62
Start Over